Android app Apple app link

Halozyme Therapeutics, Inc. (HALO) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$66.09
Day's range
$68.35

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
08/07/2026 Morgan Stanley Sean Laaman $105.00 $98.15   6.98%
04/29/2026 H.C. Wainwright Mitchell Kapoor $95.00 $63.86   48.76%
12/04/2025 Goldman Sachs Corinne Jenkins $56.00 $62.82   -10.85%
05/14/2025 Morgan Stanley Sean Laaman $62.00 $66.58   -6.88%
11/15/2024 Piper Sandler Joseph Catanzaro $52.00 $46.72   11.31%
06/07/2024 H.C. Wainwright Mitchell Kapoor $65.00 $51.44   26.36%
06/07/2024 Piper Sandler Joseph Catanzaro $51.00 $51.44   -0.86%
06/07/2024 Wells Fargo Mohit Bansal $58.00 $51.44   12.75%
06/06/2024 Goldman Sachs Corinne Jenkins $44.00 $51.44   -14.46%

Halozyme Therapeutics Inc. FAQ's

Halozyme Therapeutics Inc. has been rated by research analysts at Wells Fargo, Morgan Stanley, Leerink Partners, H.C. Wainwright, UBS, Goldman Sachs in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.